Journals / Literatür Eczacılık Bilimleri Dergisi / 2021 / Cilt: 10 - Sayı: 3

Phytoestrogens and Breast Cancer Relationship: Systematic Review

Fitoöstrojenler ve Meme Kanseri İlişkisi: Sistematik Derleme

Pages
322–331
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review includes literature evaluating the relationship between BC and the most commonly used phytoestrogens with cancer cell lines, animal experiments and human studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Breast cancer (BC) is the most common type of cancer in women worldwide and is the second cause of cancer-related deaths.
📊
Key Findings & Data:There are many unexplained points about metastatic BC, especially in the Stage 4.
💡
Conclusion & Impact:This review includes literature evaluating the relationship between BC and the most commonly used phytoestrogens with cancer cell lines, animal experiments and human studies.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Breast cancer (BC) is the most common type of cancer in women worldwide and is the second cause of cancer-related deaths. Exposure to high levels of estrogen and its derivatives is one of the main factors leading to the development of BC. Factors such as side effects due to chemotherapy drugs used in the treatment of BC, development of resistance to drugs and relapse of the disease limit the effectiveness of the treatment. There are many unexplained points about metastatic BC, especially in the Stage 4. For this reason, there is a need to investigate new approaches regarding the prevention and treatment of BC. Phytoestrogens are polyphenolic or non-steroidal compounds that are considered secondary metabolites derived from plants. These compounds are structurally and functionally similar to estrogen and its derivatives. Phytoestrogens are used to alleviate complaints such as osteoporosis, hot flashes and sweating in the postmenopausal period. However, in order to avoid estrogen-like undesirable effects caused by of phytoestrogens, it is essential to understand the effects and correct use of phytoestrogens. This review includes literature evaluating the relationship between BC and the most commonly used phytoestrogens with cancer cell lines, animal experiments and human studies.

Özet

Meme kanseri (MK), dünya çapında kadınlarda en sık görülen kanser türü olup, kansere bağlı ölümlerin 2. nedenidir. Yüksek düzeylerde östrojen ve türevlerine maruz kalmak, MK’nin gelişmesine neden olan ana etkenlerden biridir. MK tedavisinde kullanılan kemoterapi ilaçlarına bağlı gözlenen yan etkiler, ilaçlara karşı direnç gelişmesi ve hastalığın nüks etmesi gibi faktörler tedavi etkinliğini kısıtlamaktadır. Özellikle Evre 4, metastatik MK ile ilgili aydınlatılmamış pek çok nokta bulunmaktadır. Bu nedenle MK’nin önlenmesi ve tedavisiyle ilgili yeni yaklaşımların araştırılmasına ihtiyaç duyulmaktadır. Fitoöstrojenler, bitkilerden elde edilen ikincil metabolitler olarak kabul edilen polifenolik veya steroidal olmayan bileşiklerdir. Bu bileşikler, östrojen ve türevlerine yapısal ve işlevsel olarak benzemektedirler. Fitoöstrojenler, postmenapoz dönemde osteoporoz, sıcak basması ve terleme gibi şikâyetleri hafifletmek amacıyla kullanılmaktadırlar. Ancak fitoöstrojenlerin neden olduğu östrojen benzeri istenmeyen etkilerinden kaçınmak için fitoöstrojenlerin etkilerini ve doğru kullanımını anlamak oldukça önemlidir. Bu derlemede, MK ile en yaygın kullanılan fitoöstrojenler arasındaki ilişkinin kanserli hücre hatları, hayvan deneyleri ve insan çalışmalarıyla değerlendirildiği literatürlere yer verilmiştir.

🔖

Cite This Article

ÜNÜVAR, S., ÖZEK, D. A. (2022). Phytoestrogens and Breast Cancer Relationship: Systematic Review. Literatür Eczacılık Bilimleri Dergisi, Cilt: 10 - Sayı: 3, 322–331. https://ajindex.com/articles/577575

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Rice-Evans C. Flavonoids and isoflavones: absorption, metabolism, and bioactivity. Free Radic Biol Med. 2004;36(7):827-8
  2. De Flora s, Ferguson LR. Overview of mechanisms of cancer chemopreventive agents. Mutat Res. 2005;591(1-2):8-15. Epub 2005 aug 16
  3. De Flora s, Izzotti a, D'agostini F, Balansky RM, Noonan D, albini a. Multiple points of intervention in the prevention of cancer and other mutation-related diseases. Mutat Res. 2001;480-1:9-22
  4. World Health Organization [internet]. © 2021 WHO. [Erişim tarihi: 26.03.2021]. Breast cancer. Erişim linki: 5. jiang H, Fan j, Cheng L, Hu P, Liu R. The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells. Onco Targets Ther. 2018;11:8153-63
  5. Caferoğlu z, Çiçek B. Fitoöstrojenler: yararlı mı, zararlı mı? [Phytoestrogens: useful or Harmful ?]. Bes Diy Derg. 2014;42(3):234-41. 7. özmen V. Breast cancer in Turkey: clinical and histopathological characteristics (analysis of 13.240 Patients). j Breast Health. 2014;10(2): 98-105
  6. Levine jP. Treating menopausal symptoms with a tissue-selective estrogen complex. Gend Med. 2011;8(2):57-68. 9. sinha D, sarkar N, Biswas j, Bishayee a. Resveratrol for breast cancer prevention and therapy: preclinical evidence and molecular mechanisms. semin Cancer Biol. 2016;40- 1:209-32. 10. jonsson P, Katchy a, Williams C. support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells. Endocr Relat Cancer. 2014;21(2):143-60
  7. Chen LR, Chen KH. utilization of isoflavones in soybeans for women with menopausal syndrome: an overview. Int j Mol sci. 2021;22(6): 3212. 12. jiao j, Xiang H, Liao Q. Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer. Curr Med Chem. 2010;17(30):3476-87
  8. Cos P, De Bruyne T, apers s, Vanden Berghe D, Pieters L, Vlietinck aj. Phytoestrogens: recent developments. Planta Med. 2003;69(7): 589-99
  9. Verheus M, van Gils CH, Kreijkamp-Kaspers s, Kok L, Peeters PH, Grobbee DE, et al. soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2632-8
  10. Matthews j, Celius T, Halgren R, zacharewski T. Differential estrogen receptor binding of estrogenic substances: a species comparison. j steroid Biochem Mol Biol. 2000;74(4):223-34
  11. Büyüktuncer z, Başaran aa. Fitoöstrojenler ve sağlıklı yaşamdaki önemleri [Phytoes